AMPA receptor agonists: synthesis, protolytic properties, and pharmacology of 3-isothiazolol bioisosteres of glutamic acid.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Medicinal Chemistry

• Publication date

  1997-02-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM9607212PMID 9046343
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differentiation of in vivo effects of AMPA and NMDA receptor ligands using drug discrimination methods and convulsant/anticonvulsant activity.

  1995cited by this paper
• Metabotropic glutamate receptors: novel targets for drug development.

  1995cited by this paper
• Excitatory amino acid receptor ligands: asymmetric synthesis, absolute stereochemistry and pharmacology of (R)- and (S)-homoibotenic acid.

  1995cited by this paper
• Resolution, absolute stereochemistry, and pharmacology of the S-(+)- and R-(-)-isomers of the apparent partial AMPA receptor agonist (R,S)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(R,S)-APPA].

  1994cited by this paper
• Modulation of AMPA receptor function in relation to glutamatergic abnormalities in Alzheimer's disease.

  1994cited by this paper
• GABAA receptor agonists, partial agonists, and antagonists. Design and therapeutic prospects.

  1994cited by this paper
• Molecular pharmacology of the AMPA agonist, (S)-2-amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid [(S)-APPA] and the AMPA antagonist, (R)-APPA.

  1994cited by this paper
• Excitatory amino acid receptors in schizophrenia.

  1993cited by this paper
• Excitatory amino acid receptor ligands. Synthesis and biological activity of 3-isoxazolol amino acids structurally related to homoibotenic acid.

  1992cited by this paper
• Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.

  1992cited by this paper
• Treatment of Alzheimer's Disease

  1990cited by this paper
• Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease.

  1990cited by this paper
• 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

  1990cited by this paper
• Excitatory amino acid agonists. Enzymic resolution, X-ray structure, and enantioselective activities of (R)- and (S)-bromohomoibotenic acid.

  1989cited by this paper
• Excitatory amino acids and Alzheimer's disease.

  1989cited by this paper
• A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine.

  1989cited by this paper
• Pharmacology of Amineptine: Synthesis and Updating

  1989cited by this paper
• Glutamatergic abnormalities in Alzheimer's disease and a rationale for clinical trials with L-glutamate.

  1988cited by this paper
• Cooperative Modulation of [3H]MK‐801 Binding to the N‐Methyl‐d‐Aspartate Receptor‐Ion Channel Complex by l‐Glutamate, Glycine, and Polyamines

  1988cited by this paper
• Inhibition of [3H]kainic acid receptor binding by divalent cations correlates with ion affinity for the calcium channel.

  1987cited by this paper
• Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors.

  1987cited by this paper
• Complex structure of quisqualate-sensitive glutamate receptors in rat cortex.

  1985cited by this paper
• Quantitative studies on some antagonists of N‐methyl D‐aspartate in slices of rat cerebral cortex

  1985cited by this paper
• Resolution of 5,6-dihydroxy-2-(N,N-di-n-propylamino)tetralin in relation to the structural and stereochemical requirements for centrally acting dopamine agonists.

  1985cited by this paper
• Ibotenic acid analogues. Synthesis, molecular flexibility, and in vitro activity of agonists and antagonists at central glutamic acid receptors.

  1985cited by this paper
• Synthesis and structure-activity studies on excitatory amino acids structurally related to ibotenic acid.

  1985cited by this paper
• 4,5,6,7-Tetrahydroisothiazolo[5,4-c]pyridin-3-ol and related analogues of THIP. Synthesis and biological activity.

  1983cited by this paper
• Glutamic acid agonists. Stereochemical and conformational studies of DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and related compounds.

  1982cited by this paper
• gamma-Aminobutyric acid agonists, antagonists, and uptake inhibitors. Design and therapeutic aspects.

  1981cited by this paper
• New class of glutamate agonist structurally related to ibotenic acid

  1980cited by this paper
• DIHYDROMUSCIMOL, THIOMUSCIMOL AND RELATED HETEROCYCLIC COMPOUNDS AS GABA ANALOGUES

  1979cited by this paper
• Carbon-13 nuclear magnetic resonance titration shifts in amino acids.

  1974cited by this paper
• Carbon-13 nuclear-magnetic-resonance studies on selected amino acids, peptides, and proteins.

  1973cited by this paper

• Fluorescent Isostere (Fluostere) of the Carboxylate: Design of hDHODH Fluorescent Inhibitors as Proof of Concept

  2025cites this paper
• “Design, Synthesis, and Antimicrobial Evaluation of Novel 3‐(Piperazine‐1‐yl)‐1,2‐Benzothiazole‐Linked 1,3,4‐Oxadiazoles and 1,2,4‐Triazoles: Molecular Docking and Structure‐Activity Relationship”

  2025cites this paper
• Exploring the specific chemistries of the cycloaddition reactions of 5‐benzoyl‐3(2H)‐isothiazolone and stable nitrile oxides: Insights from Density Functional Theory analysis

  2024cites this paper
• Hydroxyazoles as acid isosteres and their drug design applications—Part 1: Monocyclic systems

  2021cites this paper
• Synthesis and Biological Activity of Novel Comenic Acid Derivatives Containing Isoxazole and Isothiazole Moieties

  2018cites this paper
• Electrophysiological fingerprints of OFF bipolar cells in rat retina

  2016cites this paper
• The Mitsunobu reaction in the 21st century

  2015cites this paper
• Mechanism of Action of Low Dose Preparations from Coffea arabica , Gelsemium and Veratrum Based on in Vivo and in Vitro Neurophysiological Findings

  2015cites this paper
• O-Alkylation of 3-hydroxyisoxazoles predominates under Mitsunobu conditions

  2014cites this paper
• Probing α4βδ GABAA Receptor Heterogeneity: Differential Regional Effects of a Functionally Selective α4β1δ/α4β3δ Receptor Agonist on Tonic and Phasic Inhibition in Rat Brain

  2014cites this paper
• Isothiazoles and Benzisothiazoles

  2012cites this paper
• Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro

  2011cites this paper
• Lessons from more than 80 structures of the GluA2 ligand-binding domain in complex with agonists, antagonists and allosteric modulators.

  2011cites this paper
• Facile Carbethoxylation and Carbamoylation of Ketones

  2011cites this paper
• Five‐Membered Heterocycles: 1,2‐Azoles. Part 2. Isoxazoles and Isothiazoles

  2011cites this paper
• The role of ionotropic glutamate receptors in the dorsomedial hypothalamus in the increase in core body temperature evoked by interoceptive and exteroceptive stresses in rats

  2010cites this paper
• Design of compound libraries for fragment screening

  2009cites this paper
• Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II.

  2007cites this paper
• Chemistry of Biologically Active Isothiazoles

  2007cites this paper
• Kainate receptors and RNA editing in cholinergic neurons

  2007cites this paper
• Novel 5-substituted 1-pyrazolol analogues of ibotenic acid: synthesis and pharmacology at glutamate receptors.

  2007cites this paper
• Transformations of Acylation Products of Functionally 4-Substituted 2-Alkyl(aryl)-5-hydrazino-1,3-oxazoles into 1,3,4-Oxadiazole Derivatives

  2005cites this paper
• Ibotenic acid and thioibotenic acid: a remarkable difference in activity at group III metabotropic glutamate receptors.

  2004cites this paper
• Preparation of N-unsubstituted β-ketoamides by Rhodococcus rhodochrous-catalysed hydration of β-ketonitriles

  2004cites this paper
• Synthesis of aryl- and heteroaryl-substituted 3-benzyloxyisothiazoles via Suzuki and Negishi cross-coupling reactions.

  2004cites this paper
• Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO).

  2003cites this paper
• Selective agonist binding of (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) and 2S-(2alpha,3beta,4beta)-2-carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid (kainate) receptors: a molecular modeling study.

  2003cites this paper
• Synthesis of Some Terpene-Alcohol, Sterol, and Plant Phenol Esters of 4,5-Dichloroisothiazol-3-carboxylic Acid

  2003cites this paper
• Selective agonist binding of (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) and 2S-(2α, 3β, 4β)-2-carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid (kainate) receptors: a molecular modeling study

  2003cites this paper
• Stereostructure-activity studies on agonists at the AMPA and kainate subtypes of ionotropic glutamate receptors.

  2003cites this paper
• Novel 1-hydroxyazole bioisosteres of glutamic acid. Synthesis, protolytic properties, and pharmacology.

  2002cites this paper
• Isothiazol-3(2H)-Ones, Part I: Synthesis, Reactions and Biological Activity

  2002cites this paper
• Structural Features of ATPA and Thio-ATPA—Potent and Selective GluR5 Receptor Agonists. Crystal Structure Determinations and Quantum Chemical Calculations

  2002cites this paper
• 2-Amino-3-(3-hydroxy-1,2,5-thiadiazol-4-yl)propionic acid: resolution, absolute stereochemistry and enantiopharmacology at glutamate receptors.

  2002cites this paper
• Kainate receptor agonists, antagonists and allosteric modulators.

  2002cites this paper
• The AMPA receptor binding site: focus on agonists and competitive antagonists.

  2002cites this paper
• Discrimination between agonists and antagonists by the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid-selective glutamate receptor. A mutation analysis of the ligand-binding domain of GluR-D subunit.

  2002cites this paper
• Stereochemistry and molecular pharmacology of (S)-thio-ATPA, a new potent and selective GluR5 agonist.

  2001cites this paper
• Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core.

  2000cites this paper
• Excitatory amino acids.

  1999cites this paper
• Pharmacological differentiation of kainate receptors on neonatal rat spinal motoneurones and dorsal roots.

  1998cites this paper
• Chapter 29. Bioinorganic chemistry

  1998cites this paper
• Excitatory amino acids.

  1998cites this paper
• Excitatory amino acid receptor ligands: resolution, absolute stereochemistry, and enantiopharmacology of 2-amino-3-(4-butyl-3-hydroxyisoxazol-5-yl)propionic acid.

  1998cites this paper
• Structure--activity studies for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid receptors: acidic hydroxyphenylalanines.

  1997cites this paper
• Bioisosterically modified dipeptide excitatory amino acid receptor antagonists containing 3-oxygenated isothiazole ring systems.

  1997cites this paper
• AMPA receptor agonists, antagonists and modulators: their potential for clinical utility

  1997cites this paper
• Structural characteristics of isoxazol-3-ol and isothiazol-3-ol, carboxy group bioisosteres examined by X-ray crystallography and ab initio calculations

  1997cites this paper